FDA names agency critic Prasad as top vaccine official By Dan Levine and Julie Steenhuysen Reuters May 6, 2025 U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has criticized FDA leadership and COVID-19 mandates, as director o…
FDA delays decision on Stealth BioTherapeutics' rare genetic disorder drug Apr 29, 2025 (Reuters) -The U.S. Food and Drug Administration has delayed its decision on marketing approval for Stealth BioTherapeutics' treatment for a r…
FDA puts clinical hold on Atara's trials for cancer cell therapy Reuters Jan 21, 2025 Atara Biotherapeutics on Tuesday said U.S. Food and Drug Administration has placed a clinical hold on its trials for cancer cell therapy.
